低剂量辐射改善瘤免疫微环境,增强抗CTLA-4疗法的效果
Jigang Dong1, Ying Qi1, Sha Sha1
1Qingdao People’s Hospital Group (Jiaozhou), Jiaozhou Central Hospital of Qingdao, China
Iranian journal of immunology : IJI
|March 10, 2025
概括
低剂量放射治疗 (LDR) 与免疫检查点抑制剂相结合,在抑制肺癌生长方面显示出有前途. 低激活剂改变了瘤的微环境,增加了有益的免疫细胞和细胞因子,表明了潜在的临床应用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 辐射疗法 辐射疗法
背景情况:
- 放射治疗 (RT) 通过DNA损伤损害瘤细胞.
- 高剂量的RT (HDR) 可以损害正常细胞并抑制免疫力.
- 低剂量RT (LDR) 可能独特地影响瘤微环境 (TME).
研究的目的:
- 研究将LDR与免疫检查点抑制剂相结合的协同效应.
主要方法:
- 用小鼠肺癌模型对四组进行了研究:负对照,LDR,抗CTLA-4和LDR+抗CTLA-4.
- 分析了瘤体积,免疫细胞透 (CD8+T细胞,Treg细胞) 和细胞因子水平 (IFN,CXCL9,CXCL10,CXCL11).
主要成果:
- LDR + 抗CTLA-4 组显示瘤生长速度最慢.
- 仅LDR就显示出抑制瘤生长的趋势.
- 在瘤中,LDR增加了CD8+T细胞和降低了Treg细胞,同时增加了IFN和相关的化学激素.
结论:
- 通过增强干扰素生产,LDR调节瘤免疫微环境.
- 全身LDR和抗CTLA-4的联合治疗有效地抑制了小鼠的瘤生长.
- 这些发现表明LDR在癌症治疗中的潜在临床意义.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
555
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
